Liver Diseases, Parasitic: Clinical Trials

1 trial for Liver Diseases, Parasitic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Liver Diseases, Parasitic: new trials by email Literature Review of Liver Diseases, Parasitic trials Research Report on Liver Diseases, Parasitic

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis
Oxfendazole, Triclabendazole - Fascioliasis
Phase 2Not yet recruitingUniversidad Peruana Cayetano Heredia3362026-08-152026-06-03

Narrower conditions

Fascioliasis (1)

Broader conditions

Digestive System Diseases (1)  ·  Helminthiasis (1)  ·  Infections (1)  ·  Liver Diseases (1)  ·  Parasitic Diseases (1)  ·  Trematode Infections (1)

Interventions

Triclabendazole (1)  ·  oxfendazole (1)

Sponsors

Universidad Peruana Cayetano Heredia (1)

Top investigators

Hector H Garcia, MD PhD (1)  ·  Lourdes Rodriguez, MD (1)  ·  Miguel M Cabada, MD MSc (1)

NIH funding

U01AI155323 (1)